In the 72-week Phase 3 SURMOUNT-1 trial in 2,539 adults without diabetes, mean weight change was 20.9% at the 15 mg dose, against 3.1% with placebo.
Jastreboff AM et al., N Engl J Med 2022Free shipping over €250 · Tracked, discreet delivery in Europe
premium-grade research peptides
Tirzepatide (GLP-2)10 mg
Lyophilized peptide · single vial
What it is
Tirzepatide is a synthetic 39-amino-acid peptide that activates both the GIP and the GLP-1 receptor, so it is described as a dual incretin receptor agonist. It is not a GLP-2 agonist. It is one of the most heavily trialled compounds in obesity and type 2 diabetes research, with completed Phase 3 programmes.
- Class
- GLP-1 & Metabolic
- Formula
- Tirzepatide (GLP-2) · 10 mg
- Format
- Lyophilized powder
How it works
Tirzepatide is a dual GLP-1 and GIP receptor agonist studied for weight reduction and glycemic control in clinical research.
GLP-1
Turns down appetite signaling
GLP-1 receptor activation acts on appetite centers in the brain and slows gastric emptying, studied for reduced food intake.
GIP
The second receptor
Tirzepatide also activates the GIP receptor, a second incretin pathway thought to add to its metabolic effects.
Dual
Two incretins, one molecule
The dual mechanism is studied for greater weight reduction than GLP-1-only agonists in comparative clinical trials.
Key benefits
- Lyophilized powder, reconstituted for repeatable preparation.
- COA-verified identity and purity, batch by batch.
- Research-use plans built around a compound-specific question.
Laboratory research only. Not for human or veterinary use.
What published research is studying
Human clinical data- Weight reduction in adults with obesity or overweight without diabetes (Phase 3)
- Weight reduction in adults with obesity and type 2 diabetes (Phase 3)
- Glycaemic control compared with semaglutide in type 2 diabetes (Phase 3)
- Tolerability, discontinuation, and hypoglycaemia rates across doses
Human evidence is extensive, with several large randomised Phase 3 trials published in peer-reviewed journals and long dosing periods.
Key research findings and references
Key research findings
In that same trial, 57% of the 15 mg group reached a weight reduction of 20% or more, compared with 3% on placebo.
Jastreboff AM et al., N Engl J Med 2022In a 40-week open-label Phase 3 trial in 1,879 adults with type 2 diabetes, HbA1c fell 2.30% at 15 mg, against 1.86% with semaglutide 1 mg.
Frias JP et al., N Engl J Med 2021In the 72-week SURMOUNT-2 trial in 938 adults with obesity and type 2 diabetes, mean weight change was 14.7% at 15 mg, against 3.2% with placebo.
Garvey WT et al., Lancet 2023Published study duration
- Phase 3 obesity trial: 72 weeks, including a 20-week dose-escalation period (NCT04184622).
- Phase 3 comparison against semaglutide in type 2 diabetes: 40 weeks (NCT03987919).
- Phase 3 trial in obesity with type 2 diabetes: 72 weeks (NCT04657003).
Research endpoints
- Percent change in body weight from baseline
- Proportion reaching 5% or 20% weight reduction
- Change in HbA1c from baseline
- Discontinuation due to adverse events
- Hypoglycaemia and gastrointestinal adverse event rates
References
- Jastreboff AM et al., N Engl J Med 2022. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
- Frias JP et al., N Engl J Med 2021. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2)
- Garvey WT et al., Lancet 2023. Tirzepatide once weekly for obesity in people with type 2 diabetes (SURMOUNT-2)
- ClinicalTrials.gov NCT04184622. SURMOUNT-1, tirzepatide in participants with obesity or overweight
- ClinicalTrials.gov NCT03987919. Tirzepatide versus semaglutide added to metformin in type 2 diabetes
Summaries of published research, for context only. Research use only. Not for human or veterinary use.
premium-grade research peptides
Tirzepatide (GLP-2)10 mg
Choose your vial
Choose strength
Quantity
1 vial
Add 2 more, save 5%
1 × Tirzepatide (GLP-2) · 10 mg€70 / vial
€70
Free1 × 3 ml bacteriostatic water · 10 × 0.5 ml syringes · 10 × alcohol swabs · uu.life research handling card
- €180 to free shipping
- Ships in 1-2 business days
- Discreet EU
What you get
- 1 × Tirzepatide (GLP-2) · 10 mg
Medical supply kitFreeOne kit with every vial1 × 3 ml bacteriostatic water10 × 0.5 ml syringes10 × alcohol swabs- uu.life research handling card
One supply kit ships with every vial: the counts above follow the quantity.
Optional spare suppliesHow To Use The Vials
The standard supplies above ship free with every vial. Add extras only if the research plan needs more.
Independently lab tested
99%+ purity standard
Identity verified by LC-MS
Batch COA available
Tracked delivery to European Union
Research bundles
Explore research bundles
Curated pairs and blends this compound is studied alongside. Priced live from the catalogue.
Research pairLean & Glow bundle
Retatrutide + GHK-Cu
Weight research paired with skin research. A triple-receptor peptide studied for weight reduction, next to a copper peptide studied for collagen support.
- Includes
- Retatrutide€99
- GHK-Cu€49
Research handling
Full handling guide- 01
Lyophilized, sealed, batch-numbered
Each vial ships as a freeze-dried powder under an inert seal, tied to the batch on its Certificate of Analysis.
- 02
Store cold and dark
Unopened vials are kept refrigerated at 2-8°C away from light. Reconstituted material is stored refrigerated and used within the window the research plan defines.
- 03
Reconstitute with bacteriostatic water
The included bacteriostatic water is added slowly down the vial wall and the vial is swirled, never shaken.
- 04
Research use only
Supplied for laboratory research. Not for human or veterinary use. Handle with the personal protective equipment the laboratory requires.
Before you order
What ships in the box?
The vials selected, plus a free supply kit with every vial: one 3 ml bacteriostatic water, ten 0.5 ml syringes and ten alcohol swabs per vial, and the uu.life research handling card.
How does volume pricing work?
The price per vial depends on how many vials of the same strength are on the line. 3-4 vials take 5% off, 5 or more take 10% off. The discount is applied automatically and shows on the product page, in the cart and at checkout.
Is every batch tested?
Yes. Every batch is tested by an independent laboratory for identity and purity, and the Certificate of Analysis is linked from this page and the lab-testing library.
How fast is delivery?
Orders are typically dispatched within 1-2 business days and arrive across most of Europe in 3-5 business days, tracked, in discreet packaging. Orders over €250 ship free, and Shipping Protection can be added at checkout.
Is this for human use?
No. Every product is sold for laboratory research only and is not for human or veterinary use.
Ready to order Tirzepatide (GLP-2)?
Choose a strength and quantity above. Volume pricing applies automatically.
Quality you can trace.
Batch-tested purity
Every vial ships with a Certificate of Analysis from an independent third-party lab. No exceptions.
Fast shipping
Orders are typically dispatched within 1-2 business days. Most European deliveries arrive in 3-5 business days.
Replacement guarantee
Arrived damaged? Send photos and the order number and a replacement is arranged.
You may also research.
Most ordered. The most ordered research line over the last 90 days.GLP-1 & MetabolicRetatrutideTriple agonist€99/ vial1
Best seller. Among the most ordered research lines over the last 90 days.GLP-1 & MetabolicTesamorelinVisceral fat10 mg€95/ vial1
Trending. Leads demand in its research class.GLP-1 & MetabolicMOTS-CMitochondrial40 mg€185/ vial1
GLP-1 & Metabolic5 Amino 1MQNNMT · metabolism5 mg€49/ vial1